Pfizer expected to seek approval for additional COVID-19 reminder for seniors

WASHINGTON (AP) — Drugmaker Pfizer is expected to seek approval this week for an additional COVID-19 booster dose for the elderly, according to a person familiar with the matter.

This would add a fourth dose to the regimen, which currently consists of a primary series of two injections, followed months later by a booster dose, with the aim of providing maximum protection for the population over 65 who have been the hardest hit by the pandemic. .

The Food and Drug Administration and the Centers for Disease Control must approve the request. The person who spoke about Pfizer’s next clearance request spoke on condition of anonymity because the person was not authorized to speak publicly.

“We continue to collect and assess all available data and we are in ongoing and open dialogue with regulators and health authorities to help inform a COVID-19 vaccine strategy as the virus evolves,” the door said. -word of Pfizer, Jerica Pitts.

Speaking to CBS’ ‘Face the Nation’ on Sunday, Pfizer CEO Albert Bourla said: ‘At this time, as we have seen, there is a need, a fourth booster at this time. The protection you get from the third is pretty good, actually pretty good for hospitalizations and deaths. It’s not very good against infections, but doesn’t last very long. But we’re just submitting that data to the FDA and then we’ll see what the experts say outside of Pfizer as well.


Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.

Sara Adm

Amateur tv aficionado. Freelance zombie junkie. Pop culture trailblazer. Organizer. Web buff. Social media evangelist.
Back to top button